Newfoundland and Labrador Prescription Drug Program

Bulletin #27- 2008 08 27

    Dear Provider:

Effective August 27, 2008, the benefit status, under the Newfoundland and Labrador Prescription Drug Program will be as indicated below for the following products: 

 Open Benefit for All Plans and Special Authorization for the Cystic Fibrosis Program:

 Apo-Timop Gel                                     0.5% Ophthalmic Solution          02290812                      Apotex

 

Special Authorization for All Plans and Special Authorization for the Cystic Fibrosis Program:

Apo-Nizatidine                                      150mg Capsules                        02220156                      Apotex

Apo-Nizatidine                                      300mg Capsules                        02220164                      Apotex

 

 

 

   ECS080827